My Fund Comparison
Initilizing list...
|
Tekla World Healthcare Fund as of
07/30/2021
| NYSE /
THW |
Asset Class:
Sector Equity Funds
|
1 YR Lipper Avg:
30.77% |
| Growth of $10K |
|
| Avg Annual Total Return % |
| |
10 YR |
5 YR |
1 YR |
YTD |
| Market Return |
-- |
13.15% |
25.64% |
11.29% |
| Lipper Pct. Rank |
-- |
36 |
73 |
67 |
|
| NAV Return |
-- |
9.15% |
20.19% |
13.70% |
| Lipper Pct. Rank |
-- |
58 |
71 |
34 |
| Premium/Discount History |
|
| Premium/Discount |
| 10 YR Avg |
5 YR Avg |
YTD Avg |
|
-- |
-4.443% |
3.360% |
|
| NAV |
$15.91 |
Market Price |
$16.70 |
| Net Change |
$0.02 |
Market Change |
$0.10 |
| Premium/Discount |
4.97% |
| 1 YR NAV Return |
20.189% |
| 1 YR NAV Rank |
71 |
| 12-Mo Yield as of
6/30/2021 |
Yield
Def |
| Income Only Yield |
0.68% |
| Distribution Yield (Market) |
8.52% |
| Most Recent Income Dividend |
$0.117 |
| Ex-Div Date |
6/17/2021 |
| Most Recent Cap Gain Dividend |
$0.117 |
| Ex-Div Date |
12/19/2019 |
| Dividend Frequency |
Monthly |
| YTD Dividends |
$0.700 |
| YTD Capital Gains |
-- |
| Inception Date |
6/30/2015 |
| Fund Advisor |
Tekla Capital Management LLC |
| Manager & Tenure |
Team Managed |
| Phone |
800-426-5523 |
| Website |
www.teklacap.com |
| Total Net Assets (mil)
as of
6/30/2021 |
$580.5 |
| % Leveraged Assets
as of
9/30/2020 |
22.01% |
| Portfolio Turnover |
48.00% |
| Mgmt Fees |
1.282% |
| Expense Ratio |
2.160% |
| Fund Objective |
| The Fund seeks current income and long-term capital appreciation. Under normal market conditions, the Fund expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industries including equity securities, convertible securities and debt securities. |
|
| Top Holdings
(as of 12/31/2020) |
|
Johnson & Johnson ORD |
5.04% |
|
Abbvie Inc ORD |
4.67% |
|
Abbott Laboratories ORD |
4.25% |
|
Roche Holding AG DR |
4.05% |
|
AstraZeneca PLC DR |
3.77% |
|
UnitedHealth Group Inc ORD |
3.75% |
|
Anthem Inc ORD |
3.29% |
|
Medtronic PLC ORD |
2.79% |
|
Eli Lilly and Co ORD |
2.71% |
|
Novartis AG DR |
2.57% |
|
| Top Sectors
(as of 3/31/2021) |
|
Health Care |
92.44% |
|
Financials |
6.36% |
|
Industrials |
4.52% |
|
Non Classified Equity |
2.60% |
|
Consumer Services |
1.94% |
|
|
Resources
Aberdeen Closed-End TV
Asset TV — CEF Channel
CEF Connect
Cohen & Steers CEFs Knowledge Center
Harvest — CEFA Channel
Legg Mason CEFs
Seeking Alpha — CEFA Channel
|
|
Powered by a SySys® data & content management system.
© Thomson Reuters 2019. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|